Algae powder for vision in teens with retinitis pigmentosa
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial tests whether a powder made from a special algae can help improve vision in teenagers with retinitis pigmentosa, a genetic condition that causes vision loss. The algae contains a form of vitamin A that might protect the retina.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 18 years old.
- You have been diagnosed with retinitis pigmentosa, confirmed by a special eye test (electroretinogram).
- You are not currently taking vitamin A or beta-carotene supplements.
- You do not smoke.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have a history of cancer, heart disease, or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an extract from a type of algae that is rich in a special form of vitamin A. It may help improve vision for people with retinitis pigmentosa caused by certain gene mutations that affect how the eye processes vitamin A.
This trial tests a new medicine, DSP-3077, given as a single injection into one eye to see if it is safe for people with retinitis pigmentosa. It is for adults with advanced vision loss who have no other major eye diseases.
This trial tests whether a common antibiotic called minocycline can slow the vision loss caused by retinitis pigmentosa. It is a randomized, double-blind study, meaning neither you nor your doctor will know if you are getting the real drug or a placebo (inactive pill). If it works, it could help preserve your remaining vision.
This trial tests an experimental drug called IGT001 for people with retinitis pigmentosa, a genetic eye disease that causes vision loss. The goal is to see if it is safe and can help slow or improve vision.
This study tests whether a single injection of umbilical cord stem cells around the eye can safely help slow or improve vision loss from retinitis pigmentosa, a genetic eye disease. It also checks how long any benefits might last, using regular eye tests and a quality-of-life survey.
This trial tests whether tiny particles from stem cells, called extracellular vesicles, can help people with retinitis pigmentosa. It aims to see if these particles are safe and can improve vision.
Hear when a new Retinitis Pigmentosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.